New clinically relevant, orthotopic mouse models of human chondrosarcoma with spontaneous metastasis
MetadataShow full item record
Background: Chondrosarcoma responds poorly to adjuvant therapy and new, clinically relevant animal models are required to test targeted therapy. Methods: Two human chondrosarcoma cell lines, JJ012 and FS090, were evaluated for proliferation, colony formation, invasion, angiogenesis and osteoclastogenesis. Cell lines were also investigated for VEGF, MMP-2, MMP-9, and RECK expression. JJ012 and FS090 were injected separately into the mouse tibia intramedullary canal or tibial periosteum. Animal limbs were measured, and x-rayed for evidence of tumour take and progression. Tibias and lungs were harvested to determine the presence of tumour and lung metastases. Results: JJ012 demonstrated significantly higher proliferative capacity, invasion, and colony formation in collagen I gel. JJ012 conditioned medium stimulated endothelial tube formation and osteoclastogenesis with a greater potency than FS090 conditioned medium, perhaps related to the effects of VEGF and MMP-9. In vivo, tumours formed in intratibial and periosteal groups injected with JJ012, however no mice injected with FS090 developed tumours. JJ012 periosteal tumours grew to 3 times the non-injected limb size by 7 weeks, whereas intratibial injected limbs required 10 weeks to achieve a similar tumour size. Sectioned tumour tissue demonstrated features of grade III chondrosarcoma. All JJ012 periosteal tumours (5/5) resulted in lung micro-metastases, while only 2/4 JJ012 intratibial tumours demonstrated metastases. Conclusions: The established JJ012 models replicate the site, morphology, and many behavioural characteristics of human chondrosarcoma. Local tumour invasion of bone and spontaneous lung metastasis offer valuable assessment tools to test the potential of novel agents for future chondrosarcoma therapy.
Showing items related by title, author, creator and subject.
Schaefer, Rainer (2008)At present, most cancers are treated with surgery, radiotherapy and chemotherapy, used alone or in combination. Surgery and radiotherapy are the primary treatment modalities after early detection of cancers and they ...
Collisson, E.; Campbell, J.; Brooks, A.; Berger, A.; Lee, W.; Chmielecki, J.; Beer, D.; Cope, L.; Creighton, C.; Danilova, L.; Ding, L.; Getz, G.; Hammerman, P.; Hayes, D.; Hernandez, B.; Herman, J.; Heymach, J.; Jurisica, I.; Kucherlapati, R.; Kwiatkowski, D.; Ladanyi, M.; Robertson, G.; Schultz, N.; Shen, R.; Sinha, R.; Sougnez, C.; Tsao, M.; Travis, W.; Weinstein, J.; Wigle, D.; Wilkerson, M.; Chu, A.; Cherniack, A.; Hadjipanayis, A.; Rosenberg, M.; Weisenberger, D.; Laird, P.; Radenbaugh, A.; Ma, S.; Stuart, J.; Byers, L.; Baylin, S.; Govindan, R.; Meyerson, M.; Gabriel, S.; Cibulskis, K.; Kim, J.; Stewart, C.; Lichtenstein, L.; Lander, E.; Lawrence, M.; Getz, E.; Fulton, R.; Fulton, L.; McLellan, M.; Wilson, R.; Ye, K.; Fronick, C.; Maher, C.; Miller, C.; Wendl, M.; Cabanski, C.; Mardis, E.; Wheeler, D.; Balasundaram, M.; Butterfield, Y.; Carlsen, R.; Chuah, E.; Dhalla, N.; Guin, R.; Hirst, C.; Lee, D.; Li, H.; Mayo, M.; Moore, R.; Mungall, A.; Schein, J.; Sipahimalani, P.; Tam, A.; Varhol, Richard; Robertson, A.; Wye, N.; Thiessen, N.; Holt, R.; Jones, S.; Marra, M.; Imielinski, M.; Onofrio, R.; Hodis, E.; Zack, T.; Helman, E. (2014)Adenocarcinoma of the lung is the leading cause of cancer death worldwide. Here we report molecular profiling of 230 resected lung adenocarcinomas using messenger RNA, microRNA and DNA sequencing integrated with copy ...
Bp44mT: An orally active iron chelator of the thiosemicarbazone class with potent anti-tumour efficacyYu, Yu; Rahmanto, Y.; Richardson, D. (2012)Background and Purpose: Our previous studies demonstrated that a thiosemicarbazone iron chelator (di-2-pyridylketone-4,4-dimethyl-3- thiosemicarbazone; Dp44mT) possesses potent and selective anti-cancer activity but led ...